| scholarly article | Q13442814 |
| P50 | author | Carlo La Vecchia | Q2939207 |
| Matteo Malvezzi | Q51139737 | ||
| Matteo Rota | Q57005137 | ||
| Eva Negri | Q57796544 | ||
| P2093 | author name string | P Bertuccio | |
| F Levi | |||
| T Rosso | |||
| P2860 | cites work | Cancer statistics, 2014 | Q27861018 |
| Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update | Q30843502 | ||
| Prevention and early detection of prostate cancer | Q34371057 | ||
| Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials | Q34504891 | ||
| European cancer mortality predictions for the year 2014. | Q34661464 | ||
| Recent therapeutic advances in the treatment of colorectal cancer | Q38262231 | ||
| Lung cancer mortality in European women: trends and predictions. | Q38430318 | ||
| Pancreatic cancer: overview of descriptive epidemiology | Q38435573 | ||
| European cancer mortality predictions for the year 2013. | Q39468493 | ||
| European cancer mortality predictions for the year 2012. | Q39647032 | ||
| Trends in mortality from major cancers in the Americas: 1980-2010. | Q45257337 | ||
| Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study | Q46967620 | ||
| Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012. | Q47817140 | ||
| Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. | Q51105191 | ||
| Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. | Q51217353 | ||
| European cancer mortality predictions for the year 2011. | Q51506857 | ||
| The decline in breast cancer mortality in Europe: An update (to 2009) | Q57559245 | ||
| Trends in Mortality From Urologic Cancers in Europe, 1970–2008 | Q57559334 | ||
| Nutrition and gastric cancer with a focus on Europe | Q57560708 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 779-786 | |
| P577 | publication date | 2015-01-26 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? | |
| P478 | volume | 26 |
| Q55347997 | A Recombinant Fragment of Human Surfactant Protein D induces Apoptosis in Pancreatic Cancer Cell Lines via Fas-Mediated Pathway. |
| Q30240700 | A consensus statement on the gender perspective in lung cancer. |
| Q37745433 | A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor |
| Q38661921 | A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO). |
| Q90422597 | A simulation study of the HIFU ablation process on lung tumours, showing consequences of atypical acoustic properties in flooded lung |
| Q89738593 | ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium |
| Q92143844 | APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP |
| Q36174677 | Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study. |
| Q37345775 | Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner |
| Q38670996 | Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020. |
| Q38749966 | Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients |
| Q38573871 | Breast cancer circulating biomarkers: advantages, drawbacks, and new insights. |
| Q64119555 | Cancer Mortality Trend in Central Italy: Focus on A “Low Rate of Land Use” Area from 1982 to 2011 |
| Q40444125 | Cancer incidence and mortality attributable to alcohol consumption |
| Q57923727 | Cancer mortality in Serbia, 1991-2015: an age-period-cohort and joinpoint regression analysis |
| Q30313496 | Cancer mortality in former East and West Germany: a story of unification? |
| Q64234425 | Cancer survivorship: an integral part of Europe's research agenda |
| Q40234729 | Causes of death in long-term lung cancer survivors: a SEER database analysis |
| Q36299400 | Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines |
| Q37005619 | Characterization of different CTC subpopulations in non-small cell lung cancer |
| Q64068428 | Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population |
| Q47184322 | Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France |
| Q35683807 | Clinical utility of exemestane in the treatment of breast cancer |
| Q36289486 | Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer |
| Q26795751 | Current medical treatment of estrogen receptor-positive breast cancer |
| Q37580829 | Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II. |
| Q36046608 | Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of early-stage NSCLC from benign lung disease |
| Q33864464 | Differential diagnosis between intraductal papillary mucinous neoplasm with an associated invasive carcinoma and pancreatic ductal adenocarcinoma on ultrasonography: the utility of echo intensity and contrast enhancement. |
| Q38601833 | Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study |
| Q58608805 | Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer |
| Q46925673 | Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts |
| Q36135938 | Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review |
| Q88723227 | Effect of childhood socioeconomic conditions on cancer onset in later life: an ambidirectional cohort study |
| Q41547828 | Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patients |
| Q58567008 | Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation |
| Q39108676 | Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma. |
| Q36008908 | Estimation of optical properties of neuroendocrine pancreas tumor with double-integrating-sphere system and inverse Monte Carlo model. |
| Q38887446 | European cancer mortality predictions for the year 2017, with focus on lung cancer |
| Q92837898 | Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer |
| Q92389697 | GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol |
| Q38689014 | Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. |
| Q36021088 | Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer |
| Q36524569 | Genetic alterations in lung adenocarcinoma with a micropapillary component |
| Q39706900 | Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017. |
| Q35934222 | Heavy Smoking Is More Strongly Associated with General Unhealthy Lifestyle than Obesity and Underweight |
| Q89976796 | Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients |
| Q91960245 | Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the ra |
| Q37226830 | Improving Adjuvant Hormone Therapy Use in Medicaid Managed Care-Insured Women, New York State, 2012-2014. |
| Q54467225 | Is complete response the answer? |
| Q90385563 | Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer |
| Q42062335 | Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells |
| Q37428836 | Lithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells. |
| Q40270452 | Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07. |
| Q53073509 | Lung cancer in young women in southern Sweden: A descriptive study. |
| Q39737533 | Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials. |
| Q98770574 | Lung cancer screening, what has changed after the latest evidence? |
| Q36588574 | MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors |
| Q92715105 | MLF1 protein is a potential therapy target for lung adenocarcinoma |
| Q47217649 | Manganese-12 acetate suppresses the migration, invasion, and epithelial-mesenchymal transition by inhibiting Wnt/β-catenin and PI3K/AKT signaling pathways in breast cancer cells |
| Q40346240 | Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort |
| Q33364654 | MicroRNA in breast cancer: The association with BRCA1/2. |
| Q35820403 | Modeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic Cancer |
| Q37382561 | NEAT1 regulates pancreatic cancer cell growth, invasion and migration though mircroRNA-335-5p/c-met axis |
| Q64061744 | New insights into spectral histopathology: infrared-based scoring of tumour aggressiveness of squamous cell lung carcinomas |
| Q64085635 | Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer |
| Q95266336 | Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models |
| Q91617783 | Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls |
| Q59789508 | PGAM5 expression and macrophage signatures in non-small cell lung cancer associated with chronic obstructive pulmonary disease (COPD) |
| Q90479161 | PREPARE: PreoPerative Anxiety REduction. One-Year Feasibility RCT on a Brief Psychological Intervention for Pancreatic Cancer Patients Prior to Major Surgery |
| Q48234367 | Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients. |
| Q33793966 | Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach. |
| Q57423198 | Pancreatic cancer |
| Q26747524 | Pancreatic cancer from bench to bedside: molecular pathways and treatment options |
| Q28068665 | Pancreatic cancer: Are "liquid biopsies" ready for prime-time? |
| Q30250026 | Pancreatic cancer: yesterday, today and tomorrow. |
| Q33167097 | Percutaneous ultrasound-guided core needle biopsy of solid pancreatic masses: Results in 250 patients |
| Q64903300 | Perioperative outcome of lung cancer surgery in women: results from a Spanish nationwide prospective cohort study. |
| Q50927730 | Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer. |
| Q61809317 | Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer |
| Q44125916 | Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer. |
| Q35586733 | Potential for improvement in cancer management: reducing mortality in the European Union |
| Q47805949 | Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly |
| Q47814340 | Predictive value of p63, ki-67, and survivin expression in oral leukoplakia: A tissue microarray study. |
| Q38922208 | Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape |
| Q37536918 | Prevention of pancreatic cancer in a hamster model by cAMP decrease |
| Q92393420 | Prognostic and Predictive Values of Metabolic Parameters of 18F-FDG PET/CT in Patients With Non-Small Cell Lung Cancer Treated With Chemotherapy |
| Q48342579 | Repeat multiparametric MRI in prostate cancer patients on active surveillance |
| Q37709131 | Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells |
| Q37687464 | Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer |
| Q51459972 | Role of TRPC1 channels in pressure-mediated activation of murine pancreatic stellate cells. |
| Q55283312 | Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients. |
| Q47182931 | Screening and Biosensor-Based Approaches for Lung Cancer Detection. |
| Q64056797 | Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerability |
| Q90748414 | Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer |
| Q37709301 | Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer |
| Q91810524 | Standard Expected Years of Life Lost Due to Malignant Neoplasms in Poland, 2000-2014 |
| Q92964033 | Statistical projection methods for lung cancer incidence and mortality: a systematic review |
| Q38770598 | Subsequent thoracic cancers among patients diagnosed with lung cancer: a SEER database analysis |
| Q89994907 | Survival Benefits of Chemotherapy for Patients with Advanced Pancreatic Cancer in A Clinical Real-World Cohort |
| Q59429645 | Synthesis, Anticancer, and QSAR Studies of 2-Alkyl(aryl,hetaryl)quinazolin-4(3H)-thione's and [1,2,4]Triazolo[1,5-c]quinazoline-2-thione's Thioderivatives |
| Q50798904 | Synthesis, characterization and biological evaluation of labile intercalative ruthenium(ii) complexes for anticancer drug screening. |
| Q36852993 | THE FREQUENCY OF RISK FACTORS ON TRENDS OF PANCREATIC CANCER IN KOSOVO. |
| Q58555389 | The Impact of Nutrition and Environmental Epigenetics on Human Health and Disease |
| Q36738908 | The pepper's natural ingredient capsaicin induces autophagy blockage in prostate cancer cells |
| Q36191929 | The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma |
| Q55408644 | The synergistic effects of Apatinib combined with cytotoxic chemotherapeutic agents on gastric cancer cells and in a fluorescence imaging gastric cancer xenograft model. |
| Q28068998 | Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer |
| Q40393934 | Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value |
| Q37274350 | Total antioxidant status in lung cancer is associated with levels of endogenous antioxidants and disease stage rather than lifestyle factors - preliminary study |
| Q37631729 | mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis |
Search more.